Navigation Links
Bacteria beware: MIT student invents knock-out punch for antibiotic resistance
Date:2/27/2008

. Collins, professor of biomedical engineering at Boston University, Lu developed two bacteriophage platforms to overcome antibiotic resistance. Bacteriophage are viruses that only infect bacteria, not human cells. They have been used since the early 20th century to treat bacterial infections; however, they fell out of favor in the United States due to the advent of antibiotics. Lus work represents an exciting application of synthetic biology, which is an emerging field focused on the rational engineering of organisms to achieve novel functions.

Lu has engineered bacteriophage to boost antibiotic effectiveness. The bacteriophage carries DNA that codes for factors that target bacterial gene networks, which former treatments failed to reach, and destroys bacterial antibiotic resistance mechanisms. The weakened bacterial defenses enable antibiotics to perform better. Administered together, Lus bacteriophage and antibiotics have the potential to eliminate nearly 30,000 times more bacteria than antibiotics alone, including cells that survive antibiotic-only treatment. This combination treatment also thwarts development of stronger antibiotic resistance, which can extend the lifetime of existing and future antibiotic drugs.

While working at a hospital as part of a graduate course, I saw many patients who contracted new infections due to already-compromised immune systems or equipment that is extremely difficult to keep sterile, Lu recalled. Being infected by difficult-to-eradicate bacteria is a traumatic experience for patients and a serious public health issue that needs attention. I thought that there had to be a solution for these infections.

Penetrating Biofilms

Lu also applied his work with bacteriophage to create a new technique for reducing harmful biofilms, which are slimy layers of bacteria that develop on the surfaces of medical, industrial and food processing equipment and are difficult to penetrate and remove. Current t
'/>"/>

Contact: Julie Staadecker
jstaadecker@coneinc.com
617-939-8427
Lemelson-MIT Program
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Bacterial battle for survival leads to new antibiotic
2. Scientists identify proteins that help bacteria put up a fight
3. Silica smart bombs deliver knock-out to bacteria
4. UCF technique promises to aid doctors ability to identify, treat bacterial infections
5. Why recovery from flu may increase odds of bacterial infection
6. Bacterial toxin closes gate on immune response, Penn researchers discover
7. Barrier Technology Provides New Weapon in MRSA War: Surface Care Products Prevent Growth and Transfer of Bacteria
8. Good bacteria in women give clues for slowing HIV transmission
9. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
10. Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples
11. Researchers seek to make cavity-causing bacteria self-destruct
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bacteria beware: MIT student invents knock-out punch for antibiotic resistance
Bacteria beware: MIT student invents knock-out punch for antibiotic resistance
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...duals who suffer from irritable bowel syndrome (IB...ffects approximately 10-15% or more of the general...eeze too hard or not hard enough, causing food to ...oo slowly. The disease typically affects women, mo...
...als in the NHS have confirmed that around 1,200 jo...ue to the streamlining process following the merge...roposed cuts, which are subject to official consul... the next 18 months. The concerned unions fear the...
...ts receiving highly active anti-retroviral therapy... a break in the treatment, according to new resear...ations for HIV could be better off if they took br... could mean substantial cost savings for patients ...
...ing to a research conducted by the Department of H...high amount of caffeine intake resulted in dizzine...h department has issued strong warning to public a...e. Even coffee shops in their menu cards have ind...
Other Medicine News:Health News:Dealing with IBS 2Health News:Hundreds Of Jobs To Be Lost With The Merger Of Two Major Hospitals In UK 2
(Date:10/8/2008)...Potency of Poly-ICR as Vaccine Adjuvant, SAN DIEG...maceuticals,Corporation (TSX: NVN) today presented...proprietary Toll-like Receptor 3 agonist, Poly IC-...gress 2008 in Lyon, France.,Study results demonstr...eting the Toll-like Receptor 3 (TLR3) pathway. Dat...
(Date:10/7/2008)...wswire/ -- Prometheus Laboratories Inc., a,special...s from its,development of PROMETHEUS(R) IBS Diagno...bowel syndrome (IBS). The findings suggest measura...omarkers in blood samples,between IBS and non-IBS ...combined with a proprietary algorithm, led to the ...
(Date:10/7/2008)...- The Texas Cardiac Arrhythmia,Instit...selected as one of,only a few sites in the nation ...or a new device to treat persistent atrial fibrill...and research center specializing in heart,rhythm d...ical Center and,Texas Cardiovascular Consultants.,...
(Date:10/7/2008)...cetate Prevented Immunologic Changes Induced by ...se, Additional Data Indicates Potential in Treatin... 7 /- Alba Therapeutics Corporation,p...ek at the American,College of Gastroenterology (AC... CLIN 1001-004, the first Phase IIa trial conducte...
Breaking Medicine Technology:Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Gene Variant Boosts Risk for Stress Related Ischemia 17446 1Gene Variant Boosts Risk for Stress Related Ischemia 17446 2OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 17442 1OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 17442 2Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 1Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 2Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 3UC biology prof traces his roots to the first Earth Day 2992 1UC biology prof traces his roots to the first Earth Day 2992 2UC biology prof traces his roots to the first Earth Day 2992 3
...RE)--Jun 12, 2007 - Inspire,Pharmaceuticals, Inc. ... collaborators related to Inspire will present,inf...emy of,Allergology and Clinical Immunology (EAACI)...d at the 30th European Cystic Fibrosis,Society (EC...k,Turkey., The EAACI Congress includes two presen...
...INESS WIRE)--Jun 11, 2007 - Repros,Therapeutics In...s,from its six month study of Proellex in the trea...urope, enrolled 39,premenopausal women and has com...ree dose levels of Proellex(TM) as well as a,posit...), a GnRH,agonist also known as Lupron(R) or leupr...
Other Medicine Technology:Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 2Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 3Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 4Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 5Repros Reports That Proellex Has Demonstrated Superior Efficacy and,Safety in Endometriosis When Compared to Standard of Drug Care 6
Rapid Test Kit
The InTray™ GC is a novel device for the growth and detection of both Neisseria gonorrhoeae and Neisseria meningitidis. This product provides a long shelf life and is easily transportable as a
OneStep Strip Style Gonorrhea Test is a rapid direct binding test for the visual detection of gonorrhea antigen, in the secretory specimen and urine from urogenital system, as an aid in the diagnosis
...ser thermal keratoplasty (LTK). This procedure wa...reduction of hyperopia from +0.75 to +2.50 diopter...diopters of astigmatism and refractive stability f...surgery, LTK is not performed in an operating suit...
Medicine Products: